Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine-Reference-Cited by-同舟云学术

Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine

Published:2021-09-14 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharmacol Ther

Author:

Chalon Stephan¹,Chughlay M. Farouk¹,Abla Nada¹,Marie Tchouatieu Andre¹,Haouala Amina¹,Hutter Ben²,Lorch Ulrike²,Macintyre Fiona¹

Affiliation:

1. Medicines for Malaria Venture Geneva Switzerland

2. Richmond Pharmacology Ltd London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2404

Reference50 articles.

1. World Health Organization.World malaria report (2020). Accessed December 29 2020.

2. World Health Organization.World malaria report (2019). Accessed August 21 2020.

3. World Health Organization.Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide (2013). Accessed August 20 2020.

4. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission;Meremikwu M.M.;Cochrane Database Syst Rev,2012

5. Molecular markers of resistance to amodiaquine plus sulfadoxine‐pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger;Grais R.F.;Malar. J.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study;2023-10-13

2. Atovaquone/proguanil plus amodiaquine: CNS safety signal;Reactions Weekly;2021-09